Archive for the ‘springer retractions’ Category
According to an article in Polish-language paper Gazeta Wyborcza, Jolanta Rzymowska of the Medical University of Lublin was the subject of two disciplinary hearings, the first in February 2014, following the discovery of her plagiarism by well-known Polish fraud hunter Marek Wronski. It was determined that her 1996 paper contained word-for-word text from a paper by a team at the University of Ankara.
Ultimately, Rzymowska was given an official reprimand, rather than any harsher disciplinary action, because she copied descriptions rather than results. From a Google translation of the article: Read the rest of this entry »
Here are the ten studies from Metals and Materials International: Read the rest of this entry »
A group of researchers at the Guangdong Academy of Medical Sciences in Guangzhou, China have retracted a paper that came out of a clinical trial on transarterial chemoembolization, a targeted kind of chemotherapy.
According to the notice, one of the authors mixed up the control samples with the clinical samples, and “could not recall which samples were in the wrong group.” The paper hasn’t yet been cited, according to Thomson Scientific’s Web of Knowledge.
Here’s the notice in Medical Oncology:
Asking for a retraction was “an overbearing response, though I agree that the student screwed up big time”
Just two months after a PhD student at King Fahd University of Petroleum and Minerals in Saudi Arabia published a paper in August without the knowledge of his co-author, a professor at the university, the paper was retracted by Cellulose.
Here’s the notice for “Corrosion protection of steel sheets by chitosan from shrimp shells at acid pH,” by graduate student Ubong M. Eduok and professor Mazen M. Khaled (well, not really by Khaled): Read the rest of this entry »
One of the authors, however, told us it was an honest mistake, and that the editor pushed for retraction instead of correction “to protect this journal and its impact factor.”
In June, a paper in Tumor Biology was retracted for at least four reasons, including bad data and hiding a trial sponsor (Merck). Some people who contributed work weren’t cited; at least one author had no idea his name would be on it. And that’s just what they tell us in the notice.
Here’s the notice for “Neutropenia and invasive fungal infection in patients with hematological malignancies treated with chemotherapy: a multicenter, prospective, non-interventional study in China:” Read the rest of this entry »
We spoke with International Journal of Biometeorology editor-in-chief Scott Sheridan about the case: Read the rest of this entry »
The retraction notice indicates that the patients never consented, there was no ethical review, and the university supposedly overseeing the study had no knowledge of it:
Here’s the notice in Cancer Immunology, Immunotherapy for “Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF:” Read the rest of this entry »
The paper, titled “Further Pieces of Evidence to the Pulmonary Origin of Sevoflurane Escaping to the Operating Room During General Anaesthesia,” appeared in Cell Biochemistry and Biophysics and came from a group at various institutions in Harbin, China.